Article Text

Download PDFPDF
CASE REPORT
Acromegaly-induced cardiomyopathy with dobutamine-induced outflow tract obstruction
  1. Mahmoud A Abdelsalam1,
  2. Todd B Nippoldt2,
  3. Jeffrey B Geske1
  1. 1Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Endocrinology, Mayo Clinic, Rochester, Minnesota, USA
  1. Correspondence to Dr Jeffrey B Geske, geske.jeffrey{at}mayo.edu

Summary

A 50-year-old man with a history of acromegaly was referred for preoperative cardiac evaluation preceding trans-sphenoidal resection of a pituitary macroadenoma. Dobutamine stress echocardiography was negative for myocardial ischaemia. Resting left ventricular (LV) LV ejection fraction (LVEF) was 64% and there was hypertrophy of ventricular septum (18 mm) without resting LV outflow tract obstruction. With 40 µg/kg/min of dobutamine, the LVEF became hyperdynamic at 80%, and there was a maximal instantaneous LV outflow tract gradient of 77 mm Hg. There was no delayed myocardial enhancement on cardiac MRI and the pattern of hypertrophy was concentric. Acromegaly-induced cardiomyopathy can mimic hypertrophic cardiomyopathy in the setting of dobutamine provocation. Because cardiomyopathy is an important cause of mortality in acromegaly, diagnosis and appropriate management are critical to improve survival.

View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.